Blog
RSS FeedPosted by Michael Wonder on 27 Jul 2016
Review of pharmacy remuneration and regulation - release of discussion paper
27 July 2016 - The Chair of the Review Panel, Professor Stephen King has announced the release of the review's discussion ...
Posted by Michael Wonder on 18 Jul 2016
Generic drug approvals since the 1984 Hatch-Waxman Act
18 July 2016 - This study uses US FDA data to identify approved generic drugs manufactured between September 30, 1984, and ...
Posted by Michael Wonder on 14 Jul 2016
ICER opens national call for proposed improvements to its value assessment framework
14 July 2016 - ICER solicits input on value assessment framework; will give webinar on current version July 29th. ...
Posted by Michael Wonder on 13 Jul 2016
Next President should attack drug prices, Obama says in JAMA
12 July 2016 - Obama says ‘public option’ insurance plan should be created. ...
Posted by Michael Wonder on 12 Jul 2016
Governments need better guidance to maximise value for money: the case of Australia’s Pharmaceutical Benefits Advisory Committee
12 July 2016 - In Australia, the PBAC makes recommendations to the Minister for Health on which pharmaceuticals should be ...
Posted by Michael Wonder on 05 Jul 2016
New Zealand public help improve PHARMAC decision making
6 July 2016 - After listening to what New Zealanders had to say, PHARMAC has changed the way it makes decisions ...
Posted by Michael Wonder on 03 Jul 2016
Election 2016: 'Mediscare' makes Medicare reform harder
3 July 2016 - The success of Labor's Medicare scare campaign makes it more difficult for a Coalition or Labor government ...
Posted by Michael Wonder on 29 Jun 2016
Statement from FDA Commissioner announcing the acting director of the FDA Oncology Center of Excellence
29 June 2016 - The FDA is honored to be an integral part of the Vice President’s National Cancer Moonshot Initiative ...
Posted by Michael Wonder on 29 Jun 2016
Latest plan to cut Medicare drug payments leaves Senators skeptical
29 June 2016 - Under fire from senators in both parties, a senior federal health official told Congress on Tuesday that ...
Posted by Michael Wonder on 13 Jun 2016
Cancer Drugs Fund 2.0: a missed opportunity?
14 June 2016 - The UK National Health Service, like most other developed health care systems, has struggled with how to ...
Posted by Michael Wonder on 08 Jun 2016
The Cancer Drugs Fund
8 June 2016 - Over the past five years thousands of patients in England have been given access to new but ...
Posted by Michael Wonder on 02 Jun 2016
Statement from FDA Commissioner Robert Califf on the release of the final individual patient expanded access form
2 June 2016 - Today, the U.S. FDA finalized its efforts to streamline the process used by physicians to request expanded ...
Posted by Michael Wonder on 27 May 2016
Improving safety of first-in-human clinical trials
27 May 2016 - EMA starts EU wide reflection on necessary changes to best practices. ...
Posted by Michael Wonder on 26 May 2016
TGA updates prescription medicine clinical units
26 May 2016 - The TGA conducts a minor reallocation of prescription medicine authorisation unit work streams. ...
Posted by Michael Wonder on 25 May 2016
ASCO explains its opposition to Medicare Part B demo during key congressional hearing
17 May 2016 - Oncology community highlights experiment's lack of real-time patient protections. ...